Prostate Cancer Questions Answered, From PSA Levels to Treatment Decisions
A diagnosis of prostate cancer can be accompanied by plenty of questions for patients, caregivers and loved ones.
Q&A: Although preventive mastectomies rise, procedures still not often recommended
For many oncologists, the use of mastectomy to treat breast cancer cases can be a difficult subject to approach with patients.
Don’t skip colonoscopy for new blood-based colon cancer screening, study says
Newly available blood tests to screen for colorectal cancer sound far more appealing than a standard colonoscopy.
A drug may cause problems with chemotherapies in cancer patients with obesity. Many doctors are in the dark
A drug used to combat fungal infections in cancer patients comes with a big caveat — research shows the medicine can last twice as long in people with obesity.
Immunotherapy use for late-stage kidney, bladder cancers varies by race, socioeconomics
Immunotherapy utilization for treatment of advanced kidney or bladder cancers varied by patients’ race or socioeconomic status, according to study results.
Pharmacy Benefit Managers: The Silent Squeeze on Independent Pharmacies in America
From recent congressional hearings and ongoing investigations to anticipated legislation waiting to be signed into law, the spotlight pharmacy benefit managers (PBMs) have garnered in the past few years has reached beyond the pharmacy profession, into other facets of health care, and now has the federal government’s attention.
COA Patient Advocacy Network Adds Chapter at Central Georgia Cancer Care
The Community Oncology Alliance (COA) launched a new local chapter of its Patient Advocacy Network (CPAN) at Central Georgia Cancer Care (CGCC) in Warner Robins, Georgia, on Thursday, 10/24/2024.
After a breast cancer diagnosis, here are 10 important things you should do, experts say
One in eight women in the U.S. will be diagnosed with breast cancer at some point in their lifetime, statistics show.
Cancer Disparities in Rural Areas: The Impact of Social Determinants of Health and Access Challenges
In a Pharmacy Times interview, Nathan Vanderford, PhD, MBA, Associate Professor of Toxicology and Cancer Biology in the College of Medicine at the University of Kentucky, will discuss cancer disparities and social determinants of health experienced by patients with cancer in rural communities, using his home state of Kentucky as a case study.
Understanding the Role of Oncology Pharmacists in Academic vs Community Cancer Centers
The Hematology/Oncology Pharmacy Association (HOPA) supports hematology/oncology pharmacy professionals and promotes the role of the pharmacist in collaborative cancer care.
